Depression News

Following 2 consecutive years of decline, total suicides in the U.S. rose from nearly 46,000 in 2020 to just over 48,000 in 2021, researchers wrote in Morbidity and Mortality Weekly Report.

The proportion of teen girls in the United States who reported feeling persistently sad or hopeless increased nearly 60% from 2011 to 2021 to nearly three in five girls, according to data released Monday by the CDC.

Most Americans value the impact of their friends, family and social connections on their mental health, according to survey results from the American Psychiatric Association.

Prevalence of depressive and anxiety disorders, as well as related symptoms, was greater in patients with alopecia areata compared with the general population, according to a study.

Patients with juvenile idiopathic arthritis do not appear to have an increased risk for anxiety or depression, compared with the general population, according to data published in Pediatric Rheumatology.

The FDA has accepted a new drug application for zuranolone as a rapid-acting, once-daily, 14-day, oral treatment of postpartum depression and MDD, according to a release from the manufacturers.

Long-term joint exposure to multiple air pollutants at low concentrations may be associated with an increased risk of depression and anxiety, according to a study published in JAMA Psychiatry.

Yale School of Medicine has established a research center to examine the association of cannabis and cannabinoids with neurodevelopment and mental health, the school announced in a press release.

The American Psychiatric Association plans to align treatment of eating disorders with a focus on risk-benefit analysis of physical and psychosocial factors, according to new guidelines published in the American Journal of Psychiatry.

Biopharmaceutical company Karuna Therapeutics has announced an exclusive license agreement with biotech firm Goldfinch Bio for its investigational transient receptor potential canonical 4 and 5 channel candidates, including GFB-887.